Alpha helical membrane proteins are the targets for many pharmaceutical
drugs and play important roles in physiology and disease processes. In recent years,
substantial progress has been made in determining their atomic structure using X-ray
crystallography. However, a major bottleneck still remains; the identification of
conditions that give crystals that are suitable for structure determination. Over the
past 10 years we have been analysing the crystallisation conditions reported for alpha
helical membrane proteins with the aim to facilitate a rational approach to the design
and implementation of successful crystallisation screens. The result has been the
development of MemGold, MemGold2 and the additive screen MemAdvantage. The associated
analysis, summarised and updated in this chapter, has revealed a number of
surprisingly successfully strategies for crystallisation and detergent
selection.